# Quagen Pharmaceuticals LLC – FDA Inspection, Dec 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/quagen-pharmaceuticals-llc/3a1b6eac-9184-4d2e-b6aa-a723c03b5fdf
Source feed: FDA_Inspections

> FDA inspection 1194335 of Quagen Pharmaceuticals LLC, December 19, 2022. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194335
- Company Name: Quagen Pharmaceuticals LLC
- Inspection Date: 2022-12-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1322648 - 2026-05-19
- [FDA Inspection 1222389 - 2023-11-08](https://www.keypedia.com/records/fda_inspections/quagen-pharmaceuticals-llc/22c15808-cc5c-4265-a46e-d62b2a6a69ea)
- FDA Inspection 1085743 - 2019-03-15

Company: https://www.keypedia.com/companies/quagen-pharmaceuticals-llc/9f3a6bdf-7084-4753-aa36-3a336180eb8d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c